Publicacions
-
Molnar C, Mora J and Gonzalez C.
A Drosophila Study Model for EWS::FLI1-Induced Molecular Pathways.
Methods In Molecular Biology (clifton, N.J.) . 3084: 395-415.
-
Velázquez D, Molnar C, Reina J, Mora J and Gonzalez C.
Ancient and animal-specific regulatory modes of EWS::FLI1 revealed by a minimal yeast model.
PNAS Nexus . 5(10): .
-
Balaguer-Lluna L, Resa-Parés C, Brstilo L, Gómez-Caballero A, Baulenas-Farrés M, Mohr J, Hu Y, Aschero MR, Rodríguez A, Botteri G, Rodriguez E, Li-Chen L, Mañogil R, Marino F, Martinez N, Ruano A, García-Pelayo Á, Giron A, Mora J, Lavarino C, Sánchez-Navarro M, Teixidó M, Ormazabal-Herrero A, Artuch-Iriberri R, Unceta N, Schaiquevich P and Carcaboso AM.
CNS distribution and preclinical activity of the PI3K/AKT inhibitors inavolisib and ipatasertib in pediatric-type diffuse high-grade gliomas.
CANCER CHEMOTHERAPY AND PHARMACOLOGY . 96(1): .
-
Bruno A, Alvarez-Diduk R, Lara P, Maroli G, Cristina Larrosa Espinosa, López-Miralles S, Mora J, Rodriguez-Hernandez CJ and Merkoçi A.
Quantum-Capacitance Biosensing Enables Real-Time Monitoring of Naxitamab for Therapeutic Response Stratification in Neuroblastoma.
Small Science . 6(8): .
-
Mora J, Howard S, Moreira DC, Chinnaswami G, Epelman S, Allen C and Chantada G.
Scaling-Up Research in Childhood Cancer in Low- and Middle-Income Countries
PEDIATRIC BLOOD & CANCER . 73(6): . Nº de cites: 1
-
Santa-María López V, Felip-Badia A, Marina Caballero Bellón, Sanchez-Sierra N, Castañeda-Heredia A, Garraus-Oneca M, Gorostegui M, Simão-Rafael M, Muñoz JP, Pérez-Somarriba M, Mañe S, Planells MC, Pérez-Jaume S and Mora J.
Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio-Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse
PEDIATRIC BLOOD & CANCER . 73(4): .
-
Schneider B, Redwanz C, Celis-Passini V, Esperanza-Cebollada E, Montesdeoca S, Salaverria I, Planas-Roman S, Conde N, Camós-Guijosa M, Arnau R, Lopez-Guillermo A, Maletzki C, Jou-Munoz C, Erbersdobler A, Shokraie O, Meyer-Bahlburg A, Ballmann M, Mora J, ELENA CAMPO, Classen CF and Cardesa-Salzmann TM.
miRNA profiling in pediatric and young adult Burkitt leukemia and lymphoma
VIRCHOWS ARCHIV . : .
-
Dela Cruz FS, Stewart EA, Surdez D, Daley JD, Soragni A, Tomazou EM, Alvarez-Perez J, Feinberg TY, Amatruda JF, Ganapathi SS, Ohm JE, Heske CM, Cohen-Gogo S, Pesic D, Nash JO, Shlien A, Roundhill EA, Burchill SA, Crompton BD, Lawlor ER, Loeb DM, Delattre O, Mora J, Scotlandi K, Reed DR, Grohar PJ, Grünewald TGP, Kovar H and Bailey KM.
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort
MOLECULAR CANCER THERAPEUTICS . 25(1): 48-70. Nº de cites: 5
-
Rubio-San-Simón A, Marshall LV, Doz F, Mora J, Bielamowicz K, Corradini N, Langevin AM, Narendran A, Smith AA, Zwaan CM, Gho D, Cardenas A, Fowler S, Guizani C, Breton V, Wulff B, Bernardi R, Trippett T and Campbell-Hewson Q.
Idasanutlin in Combination with Chemotherapy or Venetoclax in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors (iMATRIX Idasa): Results of a Phase I/II, Multicenter, Multi-arm Study
Targeted Oncology . 21(1): 87-102. Nº de cites: 3
-
Figuerola-Bou E, Rios-Astorch C, Blanco E, Sanchez-Jimenez M, Táboas-Outón P, Fernandez-Isern G, Gomez-Gonzalez S, Muñoz-Aznar O, Castellano-Escuder P, Pérez-Jaume S, Garcia-López M, Prada-Varela E, Mateo-Lozano S, Riggi N, Avgustinova A, Lavarino C, Di Croce L, Sánchez-Molina S and Mora J.
KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma
CANCER RESEARCH . 85(22): 4485-4503. Nº de cites: 3
